Nanoparticles Delivering Edaravone for Targeted Brain Protection Against Stroke Damage

A novel nanoparticle system, edaravone-loaded DEX-CDIPBE (DEX-CDIPBE-ED), demonstrates enhanced neuroprotective effects in ischemic stroke models.

• DEX-CDIPBE-ED selectively releases edaravone in the ischemic penumbra during reperfusion, targeting oxidative stress.
• This nanoparticle system exhibits potent antioxidant and neuroprotective effects in neuronal cells during ischemic and reperfusion phases.
• In experiments with middle cerebral artery occlusion/reperfusion-treated rats, DEX-CDIPBE-ED prevents behavioral deficits more effectively than edaravone.
• DEX-CDIPBE-ED reduces oxidative stress and inhibits neuroinflammation in the ischemic penumbra.
• The findings suggest that DEX-CDIPBE-ED may provide a safer and more effective treatment for ischemic stroke.

Simplified